Dr. Ibrahim Albedaiwi ClinicGastroenterology, Hepatology & Endoscopy
Screening and surveillance

Liver cancer surveillance

Content date: 15 November 2026

Early liver cancer may cause no symptoms. Regular screening for those who need it can find disease at a stage with more treatment options.

Your next step

Ask whether you need liver cancer surveillance, and record your next scan date and how the result will be reviewed.

Get urgent help: Sudden severe abdominal pain, severe dizziness or fainting, vomiting blood, or new confusion: seek urgent assessment.

Which liver cancer does this refer to?

  • This usually means hepatocellular carcinoma: uncontrolled growth starting in liver cells, with increased risk in people with cirrhosis (F4) and some people with hepatitis B. It differs from cancer that began elsewhere and spread to the liver. Many spots found on imaging are benign, not cancer.
  • Surveillance means scheduled checks before symptoms for people expected to benefit. Finding a small tumor may provide more treatment options. It does not mean every test will find a tumor or every person with liver disease will develop cancer.

Who needs surveillance?

  • It is recommended for many people with cirrhosis (stage 4 scarring, F4) and some with hepatitis B, according to risk and expected benefit from treatment. Stage 3 fibrosis (F3) is not the same as cirrhosis; your specialist decides whether surveillance is needed based on the cause, risk factors and applicable guidance.
  • Not everyone with fatty liver needs this program. Your doctor determines whether it is needed and the best method for your situation.

What is the usual test?

  • Usually liver ultrasound with AFP blood testing every six months. If ultrasound quality is insufficient, your doctor may choose another method.
  • AFP measures a protein called alpha-fetoprotein; it is not a liver enzyme. An elevated result does not prove cancer by itself, and a normal result does not exclude it.

Why continue after blood tests improve?

  • Treating the virus or curing hepatitis C lowers cancer risk, but surveillance continues when cirrhosis (F4) has been established. Do not stop surveillance merely because liver enzymes or a stiffness measurement improve; your specialist sets the plan.
  • Do not substitute liver enzyme blood tests for imaging or postpone screening because you feel well.

If imaging shows a spot:

  • A spot does not automatically mean cancer. Contrast-enhanced CT or MRI may be required depending on its pattern and size.
  • Some very small spots need repeat imaging sooner, often in three to six months. Follow the specified date rather than waiting for routine screening.
  • In certain circumstances, the imaging pattern can diagnose liver cancer; in others, biopsy is needed.

If cancer is confirmed:

  • A specialist team discusses options based on tumor size and spread, liver function and overall health. Options may include surgery, ablation, catheter-based treatment, medicines or transplantation.
  • Treatment cannot be selected from tumor size alone or another patient’s experience. Ask about the treatment goal and next step.

Before leaving the clinic:

  • Know the next test date, how you will receive the result and whom to contact if it is delayed.
  • Routine surveillance does not replace assessment of new symptoms between appointments.

From the scan appointment to the next plan

  1. Set the appointment

    Record the requested scan and blood-test dates. Ask how to prepare and how to rebook if you cannot attend.

  2. Confirm the result

    Before leaving, know when and how the result will be discussed and who is responsible. No call does not mean a normal result.

  3. Record the next step

    This may be routine follow-up, earlier testing or different imaging. Follow the written plan for the result; do not wait for routine surveillance if earlier testing is requested.

  4. If results or the plan are delayed

    Contact the service that requested the test after the agreed date, and ask for an alternative contact if needed. New symptoms need assessment without waiting for results.

Routine surveillance is often every 6 months for those who need it. This is not a waiting period for an unclear result or additional testing.

© 2026 Dr. Ibrahim Albedaiwi · dralbedaiwi.com

When to get help

Sudden severe abdominal pain, severe dizziness or fainting, vomiting blood, or new confusion: seek urgent assessment.

A new spot or unclear result without a follow-up plan, unintentional weight loss or new jaundice.

Related guides

Liver cirrhosis (F4)

Hepatitis B

Hepatitis C

Benign liver lesions and cysts

Liver cancer: diagnosis and treatment

Sources

AASLD: liver cancer guidance

AASLD: surveillance and diagnosis

AASLD/IDSA chronic HBV guideline · 4 November 2025